相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
T. Hugh Jones et al.
DIABETES CARE (2011)
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study
Svetlana Y. Kalinchenko et al.
CLINICAL ENDOCRINOLOGY (2010)
Androgen Receptor-Dependent and Independent Atheroprotection by Testosterone in Male Mice
Johan Bourghardt et al.
ENDOCRINOLOGY (2010)
Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice
Mei Ni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
T. Hugh Jones et al.
ATHEROSCLEROSIS (2009)
Polymorphisms of Fractalkine Receptor CX3CR1 Gene in Patients with Symptomatic and Asymptomatic Carotid Artery Stenosis
Maria Kimouli et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease
A. Patel et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2008)
A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate
Farid Saad et al.
JOURNAL OF ANDROLOGY (2008)
Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: An effect that is independent of the classic androgen receptor
Joanne E. Nettleship et al.
CIRCULATION (2007)
Testosterone associations with erectile dysfunction, diabetes, and the metabolic syndrome
T. Hugh Jones
EUROPEAN UROLOGY SUPPLEMENTS (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Dihydrotestosterone decreases tumor necrosis factor-α and lipopolysaccharide-induced inflammatory response in human endothelial cells
GD Norata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diet and inflammation: a link to metabolic and cardiovascular diseases
K Esposito et al.
EUROPEAN HEART JOURNAL (2006)
Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men
M Zitzmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-κB-dependent pathway
AK Death et al.
ENDOCRINOLOGY (2004)
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life
CJ Malkin et al.
HEART (2004)
Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root
D Teupser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
CJ Malkin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
AD Lucas et al.
CIRCULATION (2003)
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease - The PRIME study
G Luc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse
RD Jones et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease
BWC Wong et al.
CARDIOVASCULAR PATHOLOGY (2002)
Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells
H Hatakeyama et al.
FEBS LETTERS (2002)
Effects of testosterone and 17-β-estradiol on TNF-α-induced E-selectin and VCAM-1 expression in endothelial cells -: Analysis of the underlying receptor pathways
X Zhang et al.
LIFE SCIENCES (2002)
Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: Implications in atherosclerosis
TK Mukherjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
L Nathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina - A randomized, double-blind, placebo-controlled study
KM English et al.
CIRCULATION (2000)
Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction
PM Ridker et al.
CIRCULATION (2000)
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
JS Yudkin et al.
ATHEROSCLEROSIS (2000)
分享论文
